Skip to main content

Laurus Labs

Laurus Labs Ltd is an Indian pharmaceutical manufacturing enterprise producing active pharmaceutical ingredients (APIs), finished dosage formulations, and contract development services. The company manufactures APIs for antiretrovirals, hepatitis C, oncology, and cardiovascular therapies, alongside contract manufacturing for global biopharmaceutical companies. Main revenue drivers comprise global commercial sales of active pharmaceutical ingredients, finished drug formulations, and custom synthesis service fees. Laurus Labs serves global pharmaceutical corporations, generic drug marketers, hospital networks, and public health procurement agencies across Asia, North America, Europe, and Africa. The company holds a market-leading position as a major low-cost supplier of antiretroviral APIs and active ingredients. Headquartered in Hyderabad, Telangana, India, it is listed on the National Stock Exchange of India and BSE.

9 of the funds FundTelligence covers report a position in Laurus Labs.

Legal name
Laurus Labs Ltd
Sector
Health Care
Country
India
Funds holding it
9

Funds holding Laurus Labs

Showing the 8 largest of 9 funds holding it.

Loading...